Anxiety disorders represent the largest class and burden of mental diseases in the United States (US), with related annual costs exceeding US$42 billion1,2,3. In recent years, anxiety and stress have heightened the prevalence of suicide and suicide ideation by over 16%4. Patients with chronic diseases are especially vulnerable to unintended secondary effects of mental distress or reduced cognitive function5. Current treatments for anxiety include psychotherapy, medications, or a combination of both6. However, despite this crisis, less than 50% of patients achieve full remission6,7. Anxiolytics such as benzodiazepines (BZs) and selective serotonin reuptake inhibitors (SSRIs) have significant drawbacks or produce little to no immediate effects8. Moreover, there is a relative scarcity of novel anxiolytics under development, challenged by the costly and time-consuming process of drug development9,10.
A critical step in the drug development process is the establishment and utilization of an animal model, such as mice, to study pathological changes and test drug safety and efficacy11. Current approaches to establishing anxiety animal models include 1) genetic manipulation, such as knocking out serotonin receptors (5-HT1A) or γ-aminobutyric acid A receptor (GABAAR) α subunits12; 2) chronically administering anxiety-inducers such as corticosterone or lipopolysaccharides (LPS)13,14; or 3) administering environmental stress including social defeat and maternal separation15. These methods, however, may not realistically reflect anxiety induced throughout daily life and therefore may not be suitable for investigating the underlying mechanism or testing novel drugs.
Like humans, mice and rats are highly social creatures16,17,18. Social contact and social interactions are essential for optimal brain health and are critical for proper neurodevelopment during the rearing period19. Thus, maternal separation or social isolation during the rearing period results in mice that show more anxiety, depression, and changes in neurotransmission20. Moreover, social grooming or allogrooming is a common form of bonding or comforting behavior among mice and rats that live together21. Thus, socialization is an integral part of rodent life, and isolation negatively impacts their health.
In this context, the present protocol describes a novel anxiety model to mimic the intentional or unintentional patterns of social isolation in modern life. This social isolation (SI) model minimizes perceived distractions and invasiveness and utilizes adult wild type C57BL/6 mice and Sprague-Dawley (SD) rats. The protocol presented here focuses on the anxiety mice model based on our published evidence, which showed increased anxiety-like behavior, aggression, decreased cognition, and increased neuroinflammation as a result of social isolation22,23,24. Anxiety-like behavior is confirmed by the elevated plus maze (EPM) and open field (OF) tests, while cognitive function is measured by novel object recognition (NOR) and novel context recognition (NCR) tests. This model is useful for investigating anxiety and related disorders but can also be adapted or modified to study the natural progression and development of mild cognitive impairment as well as metabolic changes due to stress.